MET and hepatocellular carcinoma: miR-34a can also potently inhibit HCC migration and invasion by directlytargeting c-Met and thereby decreasing the c-Met-induced phosphorylation ofextracellular signal-regulated kinases 1 and 2 (ERK1/2), suggesting the miR-34a playsan important role in tumor migration and invasion [[80],[81]].